氨己烯酸片(喜保宁)是治疗什么病的

(Vigabatrin) can be used as an auxiliary treatment for refractory complex epilepsy with partial seizures and for tardive dyskinesia. Vigabatrin tablets (Vigabatrin) can also be used to treat infantile spasms and Lennox-Gastaut syndrome.

Vigabatrin tablets (Vigabatrin) have significant therapeutic effects, but taking this drug for treatment will also produce certain side effects or adverse reactions. Common ones include: fatigue/drowsiness/headache/dizziness/mental confusion/depression, etc. Before receiving treatment with vigabatrin tablets (Vigabatrin), patients should go to the hospital for detailed testing and strictly take medication according to the doctor's diagnosis and treatment recommendations. The use of vigabatrin tablets (Vigabatrin) should be carried out under the guidance of an epilepsy expert or a child neurologist. Reactions after taking the medication should be reported to the doctor promptly.

Vigabatrin is not recommended in patients with pre-existing significant visual field defects. Patients should undergo system scans when starting Vigabatrin and at regular intervals for visual field defects. Visual field examinations should be performed every six months throughout treatment.

Based on the available data, the usual pattern of visual field defects is that the visual fields of both eyes are constricted along concentric circles, with this defect occurring more perirhinally than temporally. In the central visual field (within 30 degrees of eccentricity), a circular nasal defect is usually visible. Central vision will be unimpaired. However, the degree of visual field defects in patients who have used vigabatrin tablets (Vigabatrin) ranges from mild to severe. Severe cases can be disabling.

If visual field constriction is observed during the follow-up period, consideration should be given to gradually discontinuing Vigabatrin. If the decision is made to continue treatment with Vigabatrin, more frequent follow-up visual examinations should be performed to identify disease progression or threat of visual field loss.

(Vigabatrin) cannot be used at the same time with other drugs that are harmful to the retina.

Recommended related hot articles: /newsDetail/84690.html